| Huntington Disease |
1 |
1 |
| Drug Development |
0 |
0.99 |
| Biomarker |
0 |
0.38 |
| Birth |
0 |
0.38 |
| Cancer |
0 |
0.38 |
| Clinical Research |
0 |
0.38 |
| Genetics |
0 |
0.25 |
| Alzheimer Disease |
0 |
0.21 |
| Biomedical Technology |
0 |
0.13 |
| Brain |
0 |
0.13 |
| Disease-Modifying Therapy |
0 |
0.13 |
| Food and Drug Administration (FDA) |
0 |
0.13 |
| Healthcare and Medical Technology |
0 |
0.13 |
| Movement Disorder |
0 |
0.13 |
| Neurodegenerative Diseases |
0 |
0.13 |
| Salary and Compensation |
0 |
0.13 |
| Genomic Medicine |
0 |
0.12 |
| Parkinson Disease |
0 |
0.11 |
| Biologic Therapy |
0 |
0.1 |
| Revenue and Practice Management |
0 |
0.03 |